Clinical Trials Logo

Clinical Trial Summary

In France, Streptococcus pneumoniae is the leading agent bacterial involved in community lung disease and meningitis. The frequency of these infections and their mortality increase significantly in those at risk such as patients with certain chronic diseases, immunocompromised or on immunosuppressive therapy. This population, despite regular monitoring, has a limited pneumococcal vaccine coverage of around 20%. By carrying out a reconciliation of treatments upon admission to hospital, the clinical pharmacist can detect those without up to date pneumococcal vaccination status. The goal of this management is to make the patient aware of the need for vaccination and organization upon return home. Thus, this limited pneumococcal vaccination coverage would benefit from intervention by regional clinical pharmacy activities. The study investigators want to study the impact of a structured medico-pharmaceutical collaboration on pneumococcal vaccination of patients with risk on discharge from hospital. The investigators hypothesize that this collaboration in patients at risk of infection with pneumococcus could significantly increase their anti-pneumococcal vaccination coverage


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05060146
Study type Interventional
Source Centre Hospitalier Universitaire de Nimes
Contact Florent Dubois
Phone 04 66 68 38 44
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date March 2022
Completion date May 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05017519 - Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
Recruiting NCT03489018 - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants Phase 4
Recruiting NCT03696303 - Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
Active, not recruiting NCT03102840 - Understanding Pneumococcal Carriage and Disease 2017-2020
Completed NCT00189020 - Effect of Two Versus Three Pneumococcal Conjugate Vaccinations Phase 3
Completed NCT02037984 - Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) Phase 1/Phase 2
Recruiting NCT04944719 - Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
Active, not recruiting NCT03384589 - CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study Phase 2/Phase 3